This report provides exclusive insights into the COVID-19 impact on the Muscle Relaxants Drugs Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Muscle Relaxants Drugs Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Muscle Relaxants Drugs Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report
published by Infinium Global Research on muscle relaxants drugs market provides
an in-depth analysis of segments and sub-segments in global as well as regional
muscle relaxants drugs market. The study also highlights the impact of drivers,
restraints and macro indicators on the global and regional muscle relaxants
drugs market over the short term as well as long term. The report is a
comprehensive presentation of trends, forecast and dollar values of global
muscle relaxants drugs market. According to the report the global muscle
relaxants drugs market is projected to grow at a CAGR of 6.2% over the forecast
period of 2018-2024.
Muscle relaxants are
drugs that are used to relax and reduce tension in muscles. These are mainly
used to treat spasticity, muscle spasms, and cervical dystonia. Muscle
relaxants are beneficial for short-term use for acute, painful musculoskeletal
conditions. Spasticity is another term for stiff and rigid muscles caused due
to conditions such as cerebral palsy, stroke or multiple sclerosis. Muscle
spasms are temporary muscular contractions that are often associated with the
condition such as tension headache, low back pain, and fibromyalgia. Muscle
relaxants are not really a class of drugs but rather are a group of drugs of
different drugs that have an overall sedative effect.
Increasing stress and
tension levels among people due to work pressure, improper sleep, rising
accidents, and advanced drug delivery technologies are some of the factors
fueling the growth of the muscle relaxants drug market. The online shopping of
muscle relaxants are helping to increase the demand for muscle relaxant drugs.
In addition, adoption of facial relaxants for anti-aging treatment is boosting
the market growth. However, side effects caused by the muscle relaxants drugs
hinder market growth. Use of muscle relaxant drugs in different applications
and rising usage in the cosmetic industry can create a demand for muscle
relaxants drugs market in the near future.
America held the largest market share in 2017. The factors such as increase
awareness about muscle relaxant drugs, adoption of online shopping for drugs
are the factors driving growth in this region. Asia-Pacific is expected to be
the fastest growing CAGR among other regions owing to the huge population base,
rising stress/ tension level and improving healthcare infrastructures in this
The report on global
muscle relaxants drugs market covers segments such as drugs type and
distribution channel. On the basis of drugs type the global muscle relaxants
drugs market is categorized into the facial muscle relaxant market, skeletal
muscle relaxant market and neuromuscular relaxant market. On the basis of the
distribution channel, the global muscle relaxants drugs market is categorized
into drug stores, hospitals, clinics, and online stores.
The countries covered
in the North America region include the U.S., Canada, and Mexico; while
Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among
others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included
in the European region.
The U.S. drives the growth in the North
America region as it is the largest market in the region. The Asia-Pacific the region offers substantial potential for the market growth owing to rapid growth
in markets such as India and China. The APAC region is projected to experience growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the
companies in the global muscle relaxants drugs market such as Abbott
Laboratories, Mallinckrodt plc. Medtronic Neuromodulation (Medtronic Inc.),
Vertical Pharmaceuticals LLC, Johnson & Johnson, Par Sterile Products, LLC.
Endo Pharmaceuticals, Inc., SteriMax Inc., Upsher-Smith Laboratories, Inc. and
Orient Pharma Co., Ltd.
The report provides deep insights on
demand forecasts, market trends, and micro and macro indicators. In addition,
this report provides insights into the factors that are driving and restraining
the global muscle relaxants drugs market. Moreover, IGR-Growth Matrix analysis
given in the report brings insight into the investment areas that existing or
new market players can consider. The report provides insights into the market
using analytical tools such as Porter's five forces analysis and DRO analysis
of muscle relaxants drugs market. Moreover, the study highlights current market
trends and provides forecast from 2018-2024. We also have highlighted future
trends in the muscle relaxants drugs market that will impact the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings insight into the market share of the leading players. This report
will help manufacturers, suppliers, and distributors of the muscle relaxants
drugs market to understand the present and future trends in this market and
formulate their strategies accordingly.